In the bone metastasis of prostate cancer, tumor-derived PTHrP induces CCL2 from osteoblasts, which acts on the tumor cells to induce VEGF secretion and therefore promotes angiogenesis [92]. The gene discussed is CCL2; the disease is Familial prostate cancer.